clinical trial: phase i cd-352 antibody, damian green md, fred hutchinson cancer research center
Published 7 years ago • 208 plays • Length 5:01Download video MP4
Download video MP3
Similar videos
-
1:35
damian green fred hutchinson cancer research center 2 hd1080p
-
1:09:53
healthtree podcast for myeloma: dr. damian green, fred hutchinson cancer center
-
1:30
dr biran on future research directions in multiple myeloma
-
5:19
who should get mrd testing?
-
5:47
phase i clinical trial research of multiple myeloma - sarah cannon
-
3:59
single cell analysis | gareth morgan, md, phd | ims 2022
-
1:09
what are clinical trials in myeloma?
-
3:15
what is the best diet for myeloma patients to build a strong immune system?
-
3:16
end stage multiple myeloma
-
3:36
the amgen difference - our people, our values
-
1:57
what does it cost to be part of a clinical trial?
-
1:11:05
the utility of mrd testing for myeloma patient treatment and outcomes
-
23:27
clinical trials
-
6:53
laboratory assessment of immune functioning | doctors avigan and ludwig | ims 2023
-
5:03
opening keynote – multiple myeloma
-
1:00:01
breakfast with the investigators: new advances in multiple myeloma
-
24:13
new therapies, new side effects | seattle rt oct 14, 2023
-
3:40
the multiple myeloma research foundation – the future
-
6:10
phase 2 clinical trial update 1
-
3:05
every patient counts, every story matters: dr. david and ariel siegel
-
2:06
is my family at risk of developing myeloma?
-
0:59
opinion: mrd sequencing test approval in multiple myeloma